Brief: Aileron Therapeutics Announces Rebranding To Rein Therapeutics
10/01/2025 16:32
Jan 10 (Reuters) - Aileron Therapeutics Inc ALRN.O :
* ANNOUNCES REBRANDING TO REIN THERAPEUTICS
* CO'S SHARES TO BEGIN TRADING ON NASDAQ UNDER TRADING
SYMBOL
"RNTX" EFFECTIVE JAN 13
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Rein Therapeutics
See all newsBrief: Rein Therapeutics Receives U.S. FDA Fast Track Designation For Lti-03 In Idiopathic Pulmonary Fibrosis
Rein Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Rein Therapeutics Q2 net loss narrows on lower R&D spending
Rein Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Rein Therapeutics Announces Closing Of $57.5 Million Underwritten Public Offering